Wellcome Genome Campus CEO to speak at our Cambridge 'World Class Tech Cities' forum this September

Above: Robert Evans, CEO of Wellcome Genome Campus (courtesy Wellcome)

Future Cities Forum is delighted that Robert Evans, Chief Executive of Wellcome Genome Campus in Hinxton, Cambridgeshire, will be speaking at our September 'World Class Tech Cities' event which will be held at the Bradfield Centre, Cambridge Science Park.

Robert will join - among others - the Mayor of Heidelberg, Professor Dr Eckart Wurzner, the Chief Executive of Cambridge City Council, Robert Pollock, Artem Korolev, founder and Chief Executive of developer Mission Street, and Jane Hutchings, Director of the Cambridge Science Park.

Both Heidelberg and Hinxton / Wellcome Genome Campus provide sites for the European Molecular Laboratory - EMBL.

EMBL is an intergovernmental organisation, headquartered in Heidelberg. It was founded in 1974 with the mission of promoting molecular biology research in Europe, training young scientists, and developing new technologies.

The discussion panels in September will look at the challenges of providing modern infrastructure - including affordable housing - to support world class technology and life sciences clusters., as well as how to develop new models for sustainable living.

Robert has over 23 years of experience in real estate and development, primarily with Argent/Related Argent. During this time, he served as Joint Managing Partner of Argent and CEO of the 67‐acre King's Cross Estate, where he led the vision, planning, and execution of one of the world's most successful urban regeneration projects.

King's Cross is home to over 40,000 people who live, work, and study there. Robert continues to be a governor at the King's Cross Academy School, which he co‐founded. More recently, he has acted as an advisor to Homes England's Cambridge Delivery Group and is a Non‐Executive Director at Quod, a leading planning and socio‐economic consultancy.

Wellcome Genome Campus is home to some of the world's foremost institutes and organisations in genomics, biodata and computational biology, committed to delivering life-changing science with the reach, scale, and imagination to solve some of humanity's greatest challenges.

It is an expanding science community, with committed plans for new laboratories, homes, sports and schools, parks and gardens, to support growing numbers of workers, residents and visitors, their research and commercial endeavours and healthy lives. The first phase of the campus' expansion, already underway, will be one of the largest contemporary investments in the UK's life sciences infrastructure.

Above: Wellcome Genome Campus, Hinxton, Cambridgeshire (courtesy Wellcome)